Meeting Coverage Latest

ASCO GU 2021


MET Kinase Inhibitors Vs Sunitinib For pRCC

Sunitinib versus cabozantinib, crizotinib or savolitinib in metastatic papillary renal cell carcinoma (pRCC): Results from the randomized phase II SWOG 1500 study. MET signaling is a key molecular driver in papillary renal cell...

More Meeting Coverage

SABCS 2020


PhysQuiz Answers! SABCS 2020

1) In an updated analysis of the phase 2 DESTINY-Breast01 study, women with HER2-positive metastatic breast cancer ADC trastuzumab deruxtecan (Enhertu) continued to demonstrate favorable data, including a median progression-free...

AAO 2020 – Wet AMD


Take Our PhysQuiz on AMD

It’s no question that advancements in the treatment of age-related macular degeneration were...

AHA 2020


AHA 2020 Quiz Answers!

1) According to the FOURIER trial, patients treated with PCSK9 inhibitors had a reduced risk for venous thromboembolism (VTE), especially if they had elevated what? a) LDL b) Lipoprotein(a) c) Both d) None of the above The...

ACR 2020